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Abstract: In children with concomitant food allergy and atopic dermatitis (AD), uncovering the
causative food allergen is more arduous. We evaluated the basophil activation test (BAT) for its
diagnostic value in children, including those with AD, for milk or egg allergy. We simultaneously
measured serum-specific immunoglobulin E (sIgE) levels and performed BATs for cow’s milk and
egg white. We compared their overall diagnostic performance using the area under the receiver
operating characteristic curve (AUC) with the Delong method and compared them in children with
AD. Analyses were completed for 75 children for milk allergy and for 85 children for egg allergy.
The sIgE and percentage of basophils with the expression of CD63 were correlated for both milk
(r = 0.384, p < 0.001) and egg (r = 0.557, p < 0.001). The AUC of sIgE (0.701) for milk allergy was
significantly increased when combined with the BAT (0.805; p = 0.029). In children with AD, the AUC
of the BAT (0.924) for milk allergy was significantly larger than that of sIgE (0.701; p = 0.017). The BAT
is a potentially useful diagnostic tool for milk allergy in children when combined with sIgE. Moreover,
it may be a surrogate marker for milk allergy in children with AD.
Keywords: atopic dermatitis; anaphylaxis; basophil activation test; child; diagnosis; food allergy
1. Introduction
The gold standard for the diagnosis of food allergy (FA) is a double-blind, placebo-controlled
food challenge [1]. However, it is a time-consuming test and poses a risk of causing an acute allergic
reaction, which might be potentially severe [1]. Therefore, in clinical practice, the diagnosis of FA is
based on a combination of a history of immediate-type allergic reactions to food and the presence of
sensitization to causative food [2]; however, in some equivocal cases, an oral food challenge (OFC)
remains necessary. Therefore, there is a need for an accurate FA test that can reduce the need for OFC,
changing clinical practice. In addition, with increased awareness of FA among the general population,
an accurate and precise diagnosis is important to avoid unnecessary dietary restrictions and anxiety
associated with diagnostic uncertainty [3].
Atopic dermatitis (AD) is one of the most common comorbidities of FA during childhood, which
may present as immunoglobulin E (IgE)-mediated FA, non-IgE-mediated FA, or a mixture of the two [4].
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A large number of children with AD are asymptomatic to specific food allergens but may be sensitized
by them [5,6]. This inconsistent association may lead to unnecessary food restrictions in children with
moderate and severe AD [5]. When AD is accompanied by FA, clarity regarding the causative food
allergen leads to the more accurate and efficient management of AD [3–5].
Basophils are thought to be involved closely in a food allergic reaction because their activation
correlates with the development of symptoms during an OFC regardless of the tryptase level [7,8].
The basophil activation test (BAT) is a flow cytometry-based assay where the expression of activation
markers, such as CD63 and CD203c, present on the surface of basophils, is measured after stimulation
with an allergen [9]. CD63 is highly relevant to an IgE-mediated allergic reaction, which is correlated
with histamine through intracellular diamine oxidase [10].
There are various studies suggesting a good agreement between the results of BAT and those of
OFC [11,12]. In other studies, the performance of BAT in the diagnosis of allergy to different foods
has been assessed, including peanut, wheat, cow’s milk, and egg [13,14]. BAT has been suggested
to be useful for monitoring the acquisition of oral tolerance to allergenic foods naturally or under
immunotherapy [15]. Measurements of basophil sensitivity have been correlated with the threshold of
reactivity during an OFC, which can provide information about the severity of the allergic reaction
and the risk assessment [15]. However, evaluations of BAT in FA diagnosis remain scarce, and very
little information is available concerning the clinical utility of BAT for the diagnosis of FA in children
with AD.
In this study, we sought to evaluate the diagnostic performance of the BAT for milk and egg
allergy, which are two of the most commonly observed allergies in children [16,17], and to compare it
with the serum-specific IgE (sIgE) test, which is generally used for diagnosing FA. We also assessed the
utility of the BAT for diagnosing FA in children with AD. Since the BAT has been suggested to assess
the severity of an allergic reaction, we assessed the utility of the BAT for predicting the severity of milk
and egg allergy by evaluating anaphylaxis.
2. Materials and Methods
2.1. Study Design
Children who visited the outpatient clinic in Severance Children’s Hospital for a suspected adverse
reaction to food from August 2017 to March 2018 were enrolled. Diagnosis of milk or egg allergy was
based on a clinical history of repeated allergic symptoms within 2 h after ingestion of egg or milk or
a positive OFC. We included patients with IgE-mediated milk or egg allergy with symptoms of the
skin and/or mucus membranes (urticaria, increase in eczema, or swollen lips), respiratory tract (throat
tightness or shortness of breath, accompanied by signs of bronchus obstruction), or gastrointestinal
tract (nausea or vomiting) [2] and whose sIgE levels for milk or egg were >0.1 kU/L [18].
For excluding non-IgE-mediated FA, if allergic symptoms were reported as mild and delayed
gastrointestinal (abdominal discomfort, irritable behavior, or bloody stool), the presence of associated
symptoms, such as skin symptoms (wheals, rash, or edema), respiratory symptoms, or cardiovascular
symptoms, were also required for the diagnosis of FA [19]. We checked the experience of anaphylaxis to
milk and egg ingestion according to the 2011 World Allergy Organization Anaphylaxis Guidelines [20].
We simultaneously measured sIgE levels and performed the BAT for cow milk and egg white.
The study was approved by the institutional review board (IRB) of Severance Hospital (Seoul,
Korea; IRB no. 4-2017-0514). Written informed consent was obtained from the participants and
their parents.
2.2. Specific IgE Measurement
We measured sIgE levels for cow’s milk extract and egg white on an ImmunoCAP system
(UniCAP®, Thermo Fisher Scientific, Waltham, MA, USA) with the appropriate allergen caps according
to manufacturer instructions. Milk-specific sIgE values were considered positive if they were >15 kU/L
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in children aged≥1 year and 5 kU/L in those aged < 1 year [21]. Egg-specific IgE values were considered
positive if they were >7 kU/L in children aged ≥2 years and 2 kU/L in those aged <2 years [21].
2.3. The Basophil Activation Test
The BAT was performed with the Flow CAST® kit, dry-powdered cow’s milk extract, and egg
white (BÜHLMANN Laboratories AG, Schönenbuch, Switzerland), according to manufacturer
instructions. We ensured that no systemically administered antiallergenic medication, such as
corticosteroids, were administered for at least 24 h prior to blood sampling [9]. Blood samples
were stored at 2–8 ◦C and analyzed using flow cytometry (FACSCanto II, BD Biosciences, San Jose,
CA, USA) within 48 h. Homogenized 50 µL of EDTA whole blood was incubated with stimulation
substances, milk or egg extract, with 20 µL of staining reagent (anti-CD63–fluorescein isothiocyanate
and anti-CCR3–phycoerythrin mAbs) added, for 15 min at 37 ◦C in a water bath. After adding
2 mL of lysing reagent, the mixture was incubated for 5 min and centrifuged for 5 min at 500 g.
Monoclonal mouse anti-human high-affinity IgE receptor (Anti-FcεRI mAb) and N-formylmethionine
leucyl-phenylalanine (fMLP) were used as positive controls. A buffer containing calcium, heparin,
and interleukine (IL)-3 was used as a negative control. If both positive controls exhibited activation of
>10% of basophils and the negative control exhibited activation of <5% of basophils, allergen stimulation
results were regarded as valid. Allergen-induced CD63 and CCR3 expressions were evaluated using
flow cytometry (FACSCanto II, BD Biosciences). We adopted more than 15% of basophils with the
expression of CCR3 and CD63 as a positive cut-off value according to the manufacturer’s instructions.
2.4. Statistical Analysis
Continuous data were reported as the mean (±standard deviation) or median (interquartile range).
Comparisons between two groups (patients with milk allergy vs. those without, and patients with
egg allergy vs. those without) were performed using Student’s t-test for continuous variables and
the chi-square test for categorical variables. Spearman’s correlations between sIgE levels and the
percentage of basophils with the expression of CD63 were analyzed via Spearman’s rank correlation test.
We assessed diagnostic performance using receiver operating characteristic curve analysis, analyzing
the area under the curve (AUC). We compared the AUCs of sIgE, the BAT for diagnosis of milk and egg
allergy, and for anaphylaxis from milk and egg ingestion using the Delong method [22]. We generated
the values that combined the values of sIgE and BAT using a logistic regression model from milk and
egg allergy and for anaphylaxis from milk and egg ingestion. The AUCs of sIgE, the BAT, and the
combination of sIgE and BAT were also compared using the Delong methods. These comparisons
were also performed separately for patients with AD. All statistical analyses were conducted with SAS
9.2 (SAS Institute Inc., Cary, NC, USA). p < 0.05 was considered statistically significant.
3. Results
3.1. Patient Characteristics
Of the 97 children we evaluated, eight were excluded due to their blood samples exhibiting
<10% of activated basophils in the positive controls [9]. Among the 89 children included in the study,
14 declined milk-specific IgE measurement, as they had already been drinking milk without any
symptoms, and four declined egg-specific IgE measurement for a similar reason. Finally, 75 children
were evaluated for milk allergy and 85 for egg allergy in this study. Patient characteristics are
summarized in Table 1.
Among the 75 patients who were evaluated for milk allergy, 26 were diagnosed with milk allergy,
and, additionally, 33 had AD. Patients with milk allergy were older than those without milk allergy.
sIgE levels and the percentage of basophils with the expression of CD63 were higher in patients with
milk allergy than in those without milk allergy. Anaphylaxis was experienced by five patients with
milk allergy (19.2%).
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Among the 85 patients who were evaluated for egg allergy, 42 were diagnosed with egg allergy,
and, additionally, 35 had AD. Patients with egg allergy were older than those without egg allergy.
sIgE levels and the percentage of basophils with the expression of CD63 were higher in patients with
egg allergy than in those without egg allergy. Anaphylaxis was experienced by six patients with egg
allergy (14.3%). No significant difference was observed in terms of the proportion of males, the presence
of AD, or the presence of a family history of allergy between children with and those without allergy.
Among the 75 patients who were evaluated for milk allergy, 33 were diagnosed with AD.
Among the 85 patients who were evaluated for egg allergy, 35 were diagnosed with AD. Patients’
characteristics were compared between total subjects and subjects with AD, and the data are shown
in Table 2. There were no significant differences in age, sex, total IgE level, anaphylaxis, and family
history. In patients with milk or egg allergy, there were no significant differences in specific IgEs and
BAT results for milk or egg between total subjects and subjects with AD.
There was an overall significant correlation between sIgE level and the percentage of basophils
with the expression of CD63 for both milk (r = 0.384, p = 0.001) and egg (r = 0.557, p < 0.001) allergen in
total subjects (Figure 1A,D). The significant correlations between sIgE levels and the percentage of
basophils with the expression of CD63 were shown in only patients with milk (r = 0.493, p = 0.011) or
egg (r = 0.339, p = 0.028) allergy, while the correlations were not in the others without milk and egg
allergy (Figure 1B,C,E,F).
3.2. Diagnostic Performance of the BAT and sIgE
For milk allergy, the AUC was 0.701 for sIgE, 0.758 for the BAT, and 0.805 for a combination of
both (Table 3). The AUC for sIgE was significantly increased when combined with the BAT for the
diagnosis of milk allergy (p = 0.029). For egg allergy, the AUC was 0.777 for sIgE, 0.776 for the BAT,
and 0.766 for a combination of both, with no significant difference between any of the above.
We also compared the AUCs for sIgE, the BAT, and a combination of both for patients with
anaphylaxis (Table 3). There was no significant difference between any of these.
3.3. Diagnostic Performance of the BAT and sIgE for Patients with AD
We compared the AUCs of sIgE, the BAT, and a combination of both for patients with AD (Table 4).
Among the 75 patients who were evaluated for milk allergy, 33 patients had AD. Among the 33 patients,
nine were diagnosed with a milk allergy. Among the 85 patients who were evaluated for egg allergy,
35 patients had AD. Among the 35 patients, 15 were diagnosed with egg allergy. For milk allergy,
the AUCs of the BAT (0.924) and the combination (0.903) were significantly greater (p = 0.017 and
p = 0.026, respectively) than that of sIgE (0.701) in patients with AD. There was no corresponding
significant difference for egg allergy.
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Table 1. Subjects’ characteristics.
Tested for Milk Allergy (n = 75) Tested for Egg Allergy (n = 85)
Children with Milk Allergy
(n = 26)
Children without Milk Allergy
(n = 49)
Children with Egg Allergy
(n = 42)
Children without Egg Allergy
(n = 43)
Age, year 3.0 (2.0–5.2) * 1.6 (0.9–2.8) 2.6 (1.4–5.3) † 1.8 (0.9–2.5)
Male, n (%) 15 (57.7) 30 (61.2) 28 (66.7) 23 (53.5)
Total IgE, kU/L 557 (277–1210) * 90 (37–280) 296 (81–907) † 99 (33–322)
Specific IgE for milk or egg, kU/L 13.10 (2.61–34.85) * 0.19 (0.09–0.72) 14.30 (4.01–30.55) † 1.09 (0.27–3.20)
CD63+ basophils for milk or egg, % 31.8 (1.0–53.3) * 1.0 (0.5–1.5) 37.9 (11.7–57.9) † 1.9 (0.8–6.8)
Anaphylaxis, n (%) 5 (19.2) * 0 (0) 6 (14.3) † 0 (0)
Atopic dermatitis, n (%) 9 (34.6) 24 (49.0) 15 (35.7) 20 (46.5)
Family history of allergy, n (%) 7 (26.9) 18 (36.7) 15 (35.7) 14 (32.6)
Other suspected allergic foods ‡
Nuts, n (%) 6 (23.1) 7 (14.3) 5 (11.9) 5 (11.6)
Soybean, n (%) 1 (3.8) 2 (4.1) 1 (2.4) 2 (4.7)
Wheat, n (%) 4 (15.4) 4 (8.2) 6 (14.3) 3 (7.0)
Fruits and vegetables, n (%) 2 (7.7) 14 (28.6) 10 (23.8) 7 (16.3)
Fish, n (%) 2 (7.7) 4 (8.2) 4 (9.5) 3 (7.0)
Crustaceans, n (%) 1 (3.8) 4 (8.2) 2 (4.8) 3 (7.0)
IgE, immunoglobulin E, CD63+ basophils, basophil with the expression of CD63. Age, IgE levels, and CD63+ basophil levels are indicated as the median (interquartile range). * p < 0.05 vs.
without milk allergy, † p < 0.05 vs. without egg allergy. ‡ Other suspected allergic foods were reported from the children’s parents.
Table 2. Comparison of subjects’ characteristics between total subjects and subjects with AD.
Tested for Milk Allergy (n = 75) Tested for Egg Allergy (n = 85)
All (n = 75) with AD (n = 33) All (n = 85) with AD (n = 35)
Age, year 2.1 (1.1–4.6) 1.6 (0.8–4.4) 2.1 (1.1–3.6) 1.6 (0.8–2.6)
Male, n (%) 45 (60.0) 19 (57.6) 51 (60.0) 21 (60.0)
Total IgE, kU/L 156 (48–655) 113 (52–706) 155 (52–604) 99 (44–557)
Anaphylaxis, n (%) 5 (6.7) 3 (9.1) 6 (7.1) 1 (2.9)
Family history of allergy, n (%) 25 (33.3) 8 (24.2) 29 (34.1) 10 (28.6)
Milk or egg allergy, n (%) 26 (34.7) 9 (27.3) 42 (49.4) 15 (42.9)
Specific IgE for milk or egg in milk or egg allergy, kU/L 13.1 (2.6–34.9) 13.8 (7.2–47.3) 14.3 (4.0–30.6) 15.7 (5.8–64.1)
CD63+ basophils for milk or egg in milk or egg allergy, % 31.8 (0.1–53.3) 55.8 (38.4–64.9) 37.9 (11.7–57.9) 51.5 (45.4–57.6)
AD, atopic dermatitis, IgE, immunoglobulin E, CD63+ basophils, basophil with the expression of CD63. Age and IgE levels are indicated as the median (interquartile range).
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Figure 1. The overall correlation between specific immunoglobulin E (sIgE) levels and percentages of
CD63+ basophils using the basophil activation test (BAT), when testing for milk (total subjects shown
in (A), with milk allergy shown in (B), without milk allergy shown in (C)) and egg allergy (total subjects
shown in (D), with milk allergy shown in (E), without milk allergy shown in (F)). r, Spearman’s
correlation coefficient. sIgE, specific immunoglobulin E; BAT, basophil activation test, CD63+ basophils,
basophil with the expression of CD63.
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Table 3. Diagnostic performance of allergy tests in milk and egg allergy and anaphylaxis for total subjects.
Diagnosis Diagnostic Tool AUC (95% CI)
Comparison of AUCs between (p-Value)







0.373 0.157 0.029 *BAT 0.758 (0.655–0.860)




0.949 0.784 0.991BAT 0.797 (0.532–1.000)







0.989 0.830 0.781BAT 0.776 (0.687–0.865)




0.661 0.867 0.705BAT 0.577 (0.367–0.787)
Combined sIgE and BAT 0.561 (0.304–0.818)
sIgE, specific immunoglobulin E; BAT, basophil activation test; AUC, area under the receiver operating characteristic curve; CI, confidence interval; Combined, Combined sIgE and BAT.
* p < 0.05 for comparison of AUCs using the Delong method.
Table 4. Diagnostic performance of allergy tests in milk and egg allergy for patients with AD.
Diagnosis Diagnostic Tool AUC (95% CI)
Comparison of AUCs between (p-Value)
sIgE vs. BAT BAT vs. Combined sIgE vs. Combined





0.017 * 0.317 0.026 *BAT 0.924 (0.807–1.000)
Combined sIgE and BAT 0.903 (0.780–1.000)





0.768 0.712 0.146BAT 0.825 (0.693–0.957)
Combined sIgE and BAT 0.800 (0.690–0.910)
AD, atopic dermatitis; sIgE, specific immunoglobulin E; BAT, basophil activation test; AUC, area under the receiver operating characteristic curve. * p < 0.05 for comparison of AUCs using
the Delong method.
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3.4. Distributions of sIgE Levels and Percentages of basophils with the expression of CD63
Plots were constructed for the distributions of sIgE levels and percentages of basophils with the
expression of CD63, which are shown in Figure 2, for patients with milk allergy and those with egg
allergy. The right lower quadrant (shaded area) represents the area in which a patient with milk or egg
allergy tested negative in sIgE but positive in BAT. Among the 26 patients with a milk allergy who
were over 1-year-old, seven tested negative in sIgE and positive in BAT. Among them, four had AD,
and three had no AD (Figure 2A). Among the 42 patients with egg allergy, 14 were below 2 years of age
and had a diagnostic decision point as 2 kU/L of egg sIgE, and the other 28 had a diagnostic decision
point as 7 kU/L. Among 28 patients, four had no AD and tested negative in sIgE and positive in BAT
(Figure 2B).
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Figure 2. Distributions of specific immunoglobulin E (sIgE) levels and percentages of basophils with
the expression of CD63 in (A) patients with milk allergy (n = 26) and (B) patients aged ≥2 years with
egg allergy (n = 28) and (C) patients aged <2 years with egg allergy (n = 14). The right lower quadrant
(shaded area) represents the area in which a patient with milk or egg allergy tested negative in sIgE and
positive in basophil activation test (BAT). Red dots indicate patients with AD, and blue dots indicate
without AD. AD, atopic dermatitis; sIgE, specific immunoglobulin E; BAT, basophil activation test.
4. Dis ussion
In this study, we evaluated the reliability of the BAT as a diagnostic tool for milk and egg allergy in
children. The BAT was statistically significantly correlated with sIgE, and the diagnostic performance
increased when sIgE was combined with the BAT when testing for milk allergy. When testing for milk
allergy in children with AD, the BAT was also demonstrated to be a useful supportive diagnostic tool.
Cow’s milk is the most common and clinically important food allergen in children, as it usually
develops during early infancy when cow’s milk is a major nutritional source [23]. However, its diagnosis
is often challenging: its symptoms are similar to those of other conditions, including lactose intolerance
and food protein-induced enterocolitis syndrome; the reaction differs depending on the temperature to
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which the milk is heated, and OFC testing can be distressing at such an early age [24,25]. As a large
number of children outgrow their milk allergy, they should be serially evaluated for reintroduction [26].
Therefore, an accurate diagnostic tool for milk allergy is needed, and we recommend the BAT as a
useful addition.
Classical allergy tests, such as sIgE and skin prick tests, are more difficult to interpret in patients
with moderate to severe AD who have higher total IgE levels or are more likely to be sensitized by
many different sIgEs [27]. Since a skin prick test or an OFC can result in AD flare-ups, alternatives for
the diagnosis of FA in patients with moderate to severe AD are essential [28]. We revealed that the
BAT was more useful than sIgE for the diagnosis of milk allergy in children with AD. This may be
explained by the nature of the tests: the BAT reflects a functional response induced by cross-linking
of FcεRI with the allergen, whereas sIgE assesses only sensitization [29]. A previous study indicated
that basophils in AD patients without FA did not spontaneously release elevated levels of histamine,
which supports the potential of the BAT for the diagnosis of FA in patients with AD [30].
The BAT has been suggested as an alternative to OFC for predicting the clinical severity of allergic
and anaphylactic reactions [31,32]. In our study, the BAT did not provide additional information
regarding anaphylaxis to what sIgE did, and the diagnostic reliability of BAT was very low for egg
allergy. This may be due to the small number of patients in our study who experienced anaphylaxis,
and we did not re-assess OFC-induced anaphylaxis for all patients. The BAT may not be able to predict
whether anaphylaxis will occur outside the clinical setting, as there are many contributing factors,
such as the allergen dose, comorbidity with other allergic diseases, utilization of medication, and timely
and effective treatment [33].
In the past, the BAT was limited due to its direct measurement of histamine level; however,
this limitation has been removed, as activation markers are now measured on the surface of
basophils [29]. A present limitation of the BAT is that it should preferably be performed within
4 h of sampling for optimal results; however, its viability has been demonstrated up to 24 h after
sampling, under optimal storage conditions, and the manufacturer instructions for the reagents we
used indicated its use within 48 h of sampling [29,34]. In a hospital with an established laboratory,
the clinical use of the BAT is straightforward [35]. Furthermore, the BAT provides a wide variety of
allergens for diagnosis, including for various drugs, and can be used to monitor the outcome of oral
immunotherapy for FA [9,36]. However, there is a lack of consensus regarding cut-off values for the
percentage of basophils with the expression of CD63 and the ideal allergen concentration, and the
frequency of non-responders has to be considered (6–17% of the population and 8% of patients in
the present study) [9]. Overall, the BAT may be a useful supportive diagnostic tool combined with
sensitization tools, including skin prick tests or sIgE, for increasing the diagnostic accuracy of FA and
to reduce the need for OFCs.
This study has various limitations that should be considered. First, the number of study
participants was small, especially those who had undergone an OFC, and most diagnoses were based
on previous allergic reactions. Therefore, we could not assess the severity of allergic symptoms, as these
depend on, for example, the degree of baking and amount of milk or egg consumed [31]. Second,
the cut-off values of sIgE level for the diagnosis of milk and egg allergy have been reported to be
different based on racial and ethnic disparity [37]. Since we did not have the cut-off values for sIgE,
which were representative of our regional and ethnic population in diagnosing FA, we used the cut-off
values previously suggested in other studies [21,38]. We also could not make recommendations with
regard to cut-off values for the BAT, especially for patients experiencing OFC-induced anaphylaxis,
due to the small sample size. However, we suggest herein that the BAT may be of particular utility for
the diagnosis of specific FA, such as for milk, and for patients with specific comorbidities, such as AD.
In conclusion, BAT may be a supportive diagnostic tool, combined with serum sIgE, for milk
allergy in children. It may be especially useful in children with AD.
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